Urine fibroblast growth factor 23 levels in hypertensive children and adolescents
Authors:
- Magdalena ZającMZMagdalena Zając
- Agnieszka Rybi-SzumińskaARAgnieszka Rybi-Szumińska
- Anna WasilewskaAWAnna Wasilewska
Open Access
- 1 August 2015
- journal article
- Published by Croatian Medical Journals in Croatian Medical Journal
- Vol. 56 (4) , 344-350
Abstract
To determine the correlation of urinary fibroblast growth factor 23 (FGF23) excretion with blood pressure and calcium-phosphorus metabolism.The study included 42 hypertensive (17 girls) and 46 healthy children and adolescents (17 girls) aged 6-18 years ...Keywords
This publication has 36 references indexed in Scilit:
- Fibroblast Growth Factor 23 and Inflammation in CKDClinical Journal of the American Society of Nephrology, 2012
- Fibroblast Growth Factor 23 in Patients Undergoing Peritoneal DialysisClinical Journal of the American Society of Nephrology, 2011
- Vitamin D, Parathyroid Hormone, and Blood Pressure in the National Health and Nutrition Examination SurveysAmerican Journal of Hypertension, 2011
- 25‐Hydroxyvitamin D Levels and Hypertension RatesThe Journal of Clinical Hypertension, 2010
- FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney diseaseKidney International, 2010
- Parathyroid hormone and the risk of incident hypertensionJournal Of Hypertension, 2008
- Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolismAmerican Journal of Physiology-Renal Physiology, 2005
- Low-fat dairy consumption and reduced risk of hypertension: the Seguimiento Universidad de Navarra (SUN) cohortThe American Journal of Clinical Nutrition, 2005
- Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patientsKidney International, 2005
- Vitamin D regulation of the renin–angiotensin systemJournal of Cellular Biochemistry, 2003